MARKET INTRODUCTION
Premenstrual syndrome (PMS) alternatively known as premenstrual tension is a combination of physical, emotional, psychological disturbances among women of child bearing age. Premenstrual syndrome symptom occurs 1-2 weeks before the onset of menstruation and usually disappears once the menstrual bleeding starts. The exact cause of the disease is though not clear yet fluctuations in hormone level are one of the prominent reasons for onset of symptoms.

MARKET DYNAMICS
The premenstrual syndrome market is anticipated to grow owing to increasing awareness among young women about premenstrual syndrome especially in developed economies. However, rising awareness due to several government and non-government campaigns is expected to boost the sale of the medical drugs used to treat PMS. Moreover, easy availability of OTC PMS treatment drugs, the access to treatments have become easier, thus further supporting the market growth
MARKET SCOPE
The "Premenstrual Syndrome Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of in premenstrual syndrome market with detailed market segmentation by treatment type and geography. The premenstrual syndrome market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in premenstrual syndrome market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The premenstrual syndrome market is segmented on the basis of treatment type. Based on treatment type the market is segmented as painkillers, oral contraceptive pills, estrogen-only patches and implants, gonadotropin-releasing hormone (GnRH) analogues and selective serotonin reuptake inhibitors (SSRIs).
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in premenstrual syndrome market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The premenstrual syndrome market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting premenstrual syndrome market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the premenstrual syndrome market in these regions.

MARKET PLAYERS
The report covers key developments in the in premenstrual syndrome market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in premenstrual syndrome market are anticipated to have lucrative growth opportunities in the future with the rising demand for in premenstrual syndrome market in the global market. Below mentioned is the list of few companies engaged in the premenstrual syndrome market.
The report also includes the profiles of key in premenstrual syndrome market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Alva-Amco Pharmacal Cos., Inc
- Bayer, Inc.
- Bristol-Myers Squibb Company
- Chattem, Inc. (Sanofi)
- DEKK-TEC, Inc.
- GlaxoSmithKline Plc
- MetP Pharma AG
- Novartis AG
- Pherin Pharmaceuticals, Inc.
- Umecrine Mood AB
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.